2022Plos Medicine19 (12) : e1003913
Infection and transmission risks of COVID-19 in schools and their contribution to population infections in Germany: A retrospective observational study using nationwide and regional health and education agency notification data
Heinsohn T, Lange B, Vanella P, Rodiah I, Glöckner S, Joachim A, Becker D, Brändle T, Dhein S, Ehehalt S, Fries M, Galante-Gottschalk A, Jehnichen S, Kolkmann S, Kossow A, Hellmich M, Dötsch J, Krause G
2022Antimicrobial Agents and Chemotherapy66 (12) : e0103222
Respiratory Syncytial Virus Two-Step Infection Screen Reveals Inhibitors of Early and Late Life Cycle Stages
Sake S, Kosch C, Blockus S, Haid S, Gunesch A, Zhang X, Friesland M, Trummer S, Grethe C, Kühnel A, Rückert J, Duprex W, Huang J, Rameix-Welti M, Empting M, Fischer N, Hirsch A, Schulz T, Pietschmann T
2022Pathogens (basel, Switzerland)11 (12) : 1554
Type I Interferon Signaling Controls Gammaherpesvirus Latency In Vivo
Schwerk J, Kemper L, Bussey K, Lienenklaus S, Weiss S, Čičin-Šain L, Kröger A, Kalinke U, Collins C, Speck S, Messerle M, Wirth D, Brinkmann M, Hauser H, Köster M
2022Microbial Genomics8 (12) : mgen000901
Genomic epidemiology of clinical ESBL-producing Enterobacteriaceae in a German hospital suggests infections are primarily community- and regionally-acquired
Neffe L, Forde T, Oravcova K, Köhler U, Bautsch W, Tomasch J, Häussler S
2022Nature Communications13 (1) : 7415
Nasal DNA methylation at three CpG sites predicts childhood allergic disease
van Breugel M, Qi C, Xu Z, Pedersen C, Petoukhov I, Vonk J, Gehring U, Berg M, Bügel M, Carpaij O, Forno E, Morin A, Eliasen A, Jiang Y, van den Berge M, Nawijn M, Li Y, Chen W, Bont L, Bønnelykke K, Celedón J, Koppelman G, Xu C
2022Allergy77 (12) : 3663-3666
Cell-type eQTL deconvolution of bronchial epithelium through integration of single-cell and bulk RNA-seq
Qi C, Berg M, Chu X, Timens W, Kole T, van den Berge M, Xu C, Koppelman G, Nawijn M, Li Y
2022Scientific Reports12 (1) : 19858
Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations
Jacobsen H, Strengert M, Maaß H, Ynga Durand M, Katzmarzyk M, Kessel B, Harries M, Rand U, Abassi L, Kim Y, Lüddecke T, Metzdorf K, Hernandez P, Ortmann J, Heise J, Castell S, Gornyk D, Glöckner S, Melhorn V, Kemmling Y, Lange B, Dulovic A, Marsall P, Häring J, Junker D, Schneiderhan-Marra N, Hoffmann M, Pöhlmann S, Krause G, Cicin-Sain L
2022Microorganisms10 (11) : 2286
Seroepidemiology of Borrelia burgdorferi s.l. among German National Cohort (NAKO) Participants, Hanover
Hassenstein M, Janzen I, Krause G, Harries M, Melhorn V, Kerrinnes T, Kemmling Y, Castell S
2022Nature Communications13 (1) : 6894
Distinct immunological and molecular signatures underpinning influenza vaccine responsiveness in the elderly
Riese P, Trittel S, Akmatov M, May M, Prokein J, Illig T, Schindler C, Sawitzki B, Elfaki Y, Floess S, Huehn J, Błażejewski A, Strowig T, Hernandez-Vargas E, Geffers R, Zhang B, Li Y, Pessler F, Guzmán C
2022European Heart Journal43 (42) : 4496-4511
A circular RNA derived from the insulin receptor locus protects against doxorubicin-induced cardiotoxicity
Lu D, Chatterjee S, Xiao K, Riedel I, Huang C, Costa A, Cushman S, Neufeldt D, Rode L, Schmidt A, Juchem M, Leonardy J, Büchler G, Blume J, Gern O, Kalinke U, Wen Tan W, Foo R, Vink A, van Laake L, van der Meer P, Bär C, Thum T